Literature DB >> 35919826

Identifying the Optimal Age for Herpes Zoster Vaccination - Yichang City, Hubei Province, China, 2017-2019.

Meiying You1, Tianqi Wang2, Miaomiao Wang1, Wei Jiang3, Jing Jiang3, Xudong Li1, Yuehua Hu1, Dapeng Yin4.   

Abstract

What is already known about this topic?: Herpes zoster (shingles) is a common skin condition in older adults, which usually presents as a painful rash with blisters. Vaccination is the most effective method to prevent shingles. However, there is not sufficient population-based epidemiological data in China to optimize the timing of zoster vaccination. What is added by this report?: Clustering analyses of population-wide epidemiological data from the Healthcare Big Data Platform in Yichang, China showed that the average annual zoster incidence is the highest among people 55 years or older, at 10 cases per thousand persons per year, making this age group the optimal target population for vaccination. Incidence was lower but increased with age among younger adults, 28-54 years old. What are the implications for public health practice?: With limited vaccination resources, zoster vaccinations should be targeted at adults 55 years or older who are at the greatest risk for shingles. Research should be conducted to understand the risk of shingles among young and middle-aged adults and identify triggers of shingles: potentially leading to preventive measures. Copyright and License information: Editorial Office of CCDCW, Chinese Center for Disease Control and Prevention 2022.

Entities:  

Keywords:  Chinese public health; herpes zoster vaccine; shingles

Year:  2022        PMID: 35919826      PMCID: PMC9339351          DOI: 10.46234/ccdcw2022.137

Source DB:  PubMed          Journal:  China CDC Wkly        ISSN: 2096-7071


  4 in total

1.  A systematic literature review to assess the burden of herpes zoster disease in China.

Authors:  Dapeng Yin; Desirée Van Oorschot; Ning Jiang; Alen Marijam; Debasish Saha; Zhenhua Wu; Haiwen Tang; John Diaz-Decaro; Phil Watson; Xueqiong Xie; Yifan Ren; Yu He; Yang Feng
Journal:  Expert Rev Anti Infect Ther       Date:  2020-09-30       Impact factor: 5.091

2.  Gender as an independent risk factor for herpes zoster: a population-based prospective study.

Authors:  Wim Opstelten; Gerrit A Van Essen; François Schellevis; Theo J M Verheij; Karel G M Moons
Journal:  Ann Epidemiol       Date:  2006-03-03       Impact factor: 3.797

3.  Epidemiology of herpes zoster among adults aged 50 and above in Guangdong, China.

Authors:  Qi Zhu; Huizhen Zheng; Hongying Qu; Huihong Deng; Jikai Zhang; Wenjun Ma; Yongjie Lin; Xin Xie; Quan Qiu; Zhuhang Huang
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

Review 4.  Systematic review of incidence and complications of herpes zoster: towards a global perspective.

Authors:  Kosuke Kawai; Berhanu G Gebremeskel; Camilo J Acosta
Journal:  BMJ Open       Date:  2014-06-10       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.